A young girl ’s legacy: pioneering blood test can monitor rare childhood cancer
Charity launched in name of Alice Wakeling funds breakthrough that could lead to less aggressive treatment and save more livesAlice Wakeling was three when a lump began to grow on her neck. Doctors were initially puzzled but, after six weeks of tests, consultants gave her parents, David and Sara, the devastating news. Alice had rhabdomyosarcoma, a rare childhood cancer that develops in muscle or fibrous tissue.For the next four years, Alice went through gruelling bouts of chemotherapy, radiotherapy and surgery. For a brief period, it looked as if she was free from her cancer. But it returned, and Alice died in October 2019...
Source: Guardian Unlimited Science - January 15, 2023 Category: Science Authors: Robin McKie Science editor Tags: Cancer research Children's health Charities Medical research Science Society Source Type: news

Consumer Health: What do you know about these 3 rare childhood cancers?
Childhood cancer rates have been rising slightly for the past few decades, and about 10,470 children in the U.S. under the age of 15 will be diagnosed with cancer in 2022, according to the American Cancer Society. September is Childhood Cancer Awareness Month, which makes this a good time to learn about three rare types of cancers in children: retinoblastoma, rhabdomyosarcoma and Wilms' tumor. Retinoblastoma Retinoblastoma is a rare form of eye cancer that begins in the… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 26, 2022 Category: Databases & Libraries Source Type: news

What Is the Survival Rate of Rhabdomyosarcoma in Children?
Title: What Is the Survival Rate of Rhabdomyosarcoma in Children?Category: Diseases and ConditionsCreated: 5/11/2022 12:00:00 AMLast Editorial Review: 5/11/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 11, 2022 Category: Cancer & Oncology Source Type: news

Is Rhabdomyosarcoma Soft Tissue Sarcoma?
Title: Is Rhabdomyosarcoma Soft Tissue Sarcoma?Category: Diseases and ConditionsCreated: 4/20/2022 12:00:00 AMLast Editorial Review: 4/20/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 20, 2022 Category: Cancer & Oncology Source Type: news

“There’s something down there…”
Discussion: Breast tissue develops from “milk lines” of the ectoderm that extend along the anterior abdominal wall from the axilla to the labia majora. While normal breast development occurs on the upper chest, breast tissue can develop anywhere along these lines. [Fallat, Greydanus] Polythelia is the presence of an accessory nipple, and is found in 1-2% of the population, and is slightly more common in males. [Greydanus] Removal can be done for cosmetic reasons should the patient desire. Polymastia or accessory breast tissue may be found as well, but is less common than polythelia alone. Like normal breast tissue, ect...
Source: EPMonthly.com - February 1, 2022 Category: Emergency Medicine Authors: Jeffrey Lyles Source Type: news

'As my world crashed down, she kept me going'
Florence, from Leicestershire, was diagnosed with rhabdomyosarcoma, a fast-growing cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 30, 2022 Category: Consumer Health News Source Type: news

Mayo Clinic patient, physician highlighted by Conquer Cancer Foundation
Dr. Wendy Allen-Rhoades is an oncologist at Mayo Clinic in Rochester, Minnesota, with expertise in a variety of pediatric and adolescent cancers. Her experience and research background helped her develop a promising treatment plan for Kenedi, a young patient from Wisconsin. Kenedi had a rhabdomyosarcoma, a rare type of cancer that can occur at any age, but most often affects children. Using support from a 2013 Conquer Cancer Young Investigator Award, Dr. Allen-Rhoades has been… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - September 13, 2021 Category: Research Source Type: news

International study of rare childhood cancer finds genetic clues, potential for tailored therapy
Rhabdomyosarcoma, or RMS, is a rare cancer that affects the muscles and other soft tissues. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 24, 2021 Category: American Health Source Type: news

International study of rare childhood cancer finds genetic clues, potential for tailored therapy
(NIH/National Cancer Institute) In children with rhabdomyosarcoma, or RMS, a rare cancer that affects the muscles and other soft tissues, the presence of mutations in several genes, including TP53, MYOD1, and CDKN2A, appear to be associated with a more aggressive form of the disease and a poorer chance of survival. This finding is from the largest-ever international study on RMS, led by scientists at the National Cancer Institute ’ s (NCI) Center for Cancer Research, part of the National Institutes of Health. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2021 Category: Cancer & Oncology Source Type: news

Genetic discovery could help guide treatment for aggressive childhood cancer
(Institute of Cancer Research) A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma after revealing key genetic changes underlying development of the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 24, 2021 Category: International Medicine & Public Health Source Type: news

Cardinal Health(TM) Nuclear and Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK(R) Pediatric Indication
The new indication will provide accurate and precise lymph node identification in pediatric patients one month and older with melanoma, rhabdomyosarcoma or other types of solid tumors DUBLIN, Ohio, June 10, 2021 -- (Healthcare Sales & Marketing Network)... Biopharmaceuticals, Radiology, Oncology, FDA Cardinal Health, LYMPHOSEEK, sentinel lymph node biopsies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2021 Category: Pharmaceuticals Source Type: news

Autologous HER2 CAR T Cells Induce Rhabdomyosarcoma Remission Autologous HER2 CAR T Cells Induce Rhabdomyosarcoma Remission
Infusion of autologous HER2 CAR T cells after lymphodepleting chemotherapy induced remission in a child with metastatic rhabdomyosarcoma (RMS), researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 20, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Immunotherapy with CAR T cells results in exceptional patient recovery
(Baylor College of Medicine) In a clinical trial, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) T cells that were engineered to target the HER2 protein on the surface of the cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 15, 2020 Category: Cancer & Oncology Source Type: news

UCLA Mattel Children ’s Hospital helps kids trick-or-treat
Three-year-old Harmon Jones strutted in his “Black Panther” costume as he prowled the UCLA Mattel Children’s Hospital hallways and main lobby for treats. After watching a special magic show and playing some tunes led by music therapists, he wanted some Halloween candy.“My favorite part is the lollipops!” Harmon said. “I like to share them with my mommy and daddy!”For Heather and Shaw Jones, Harmon ’s parents, holidays bring some sense of the normal and community. Last summer, Harmon was diagnosed with rhabdomyosarcoma, a rare cancer that forms in soft tissue — specifically skeletal muscle tissue or someti...
Source: UCLA Newsroom: Health Sciences - November 1, 2019 Category: Universities & Medical Training Source Type: news